Home regeneron pharmaceuticals
 

Keywords :   


Tag: regeneron pharmaceuticals

Regeneron Pharmaceuticals Is My Top Pick In The Biotech Space

2016-04-03 03:15:32| Biotech - Topix.net

The shares have sold off in sympathy with the meltdown in the biotech sector, with one caveat that REGN has the best near-term pipeline in the business. Based on the strength of the near-term pipeline, I added shares as detailed to subscribers on the 13th of March.

Tags: the top space pick

 

Regeneron Pharmaceuticals Rating Reiterated by Piper Jaffray

2015-10-04 23:23:38| Biotech - Topix.net

's stock had its "hold" rating restated by stock analysts at Piper Jaffray in a research report issued to clients and investors on Sunday, Analyst Ratings.Net reports. Shares of Regeneron Pharmaceuticals traded up 1.29% during trading on Friday, reaching $479.07.

Tags: rating pharmaceuticals piper jaffray

 
 

Regeneron Pharmaceuticals major shareholder Sanofi Acquires 147,209 Shares

2015-09-27 09:48:03| Apparel - Topix.net

Regeneron Pharmaceuticals major shareholder Sanofi bought 147,209 shares of Regeneron Pharmaceuticals stock in a transaction on Wednesday, September 23rd. The shares were bought at an average cost of $534.67 per share, with a total value of $78,708,236.03.

Tags: major shares shareholder pharmaceuticals

 

Regeneron Pharmaceuticals: 2 More Factors That Could Boost Stock Price

2015-08-06 12:47:38| Biotech - Topix.net

The company is moving closer to a stage where it might consider returning some cash to shareholders, which will boost returns. Regeneron Pharmaceuticals shares rose to an all-time high level on Tuesday as the company reported solid results for the second quarter and raised its revenue guidance for the full year.

Tags: price stock factors boost

 

Regeneron Pharmaceuticals Given "Outperform" Rating at RBC Capital

2015-06-06 21:12:59| Biotech - Topix.net

REGN has been the subject of a number of other recent research reports. Analysts at Piper Jaffray reiterated a "neutral" rating and set a $484.00 price target on shares of Regeneron Pharmaceuticals in a research note on Thursday, May 21st.

Tags: rating capital pharmaceuticals rbc

 

Sites : [1] [2] [3] next »